Home | The Incidental Economist (original) (raw)
Massachusetts Led on Dementia Policy Once. Can it Lead Again?
Katherine O'Malley February 4, 2026
Massachusetts has a chance to lead on state policy around Alzheimer’s and dementia in 2026, if lawmakers choose to prioritize it.
Latest
Massachusetts Led on Dementia Policy Once. Can it Lead Again?
Katherine O'Malley February 4, 2026
Massachusetts has a chance to lead on state policy around Alzheimer’s and dementia in 2026, if lawmakers choose to prioritize it.
Latest
When Medicaid Steps Back, Hospitals Can Use 340B To Step Up
Brian Stanley January 20, 2026
Medicaid retroactive coverage changes shift costs to patients, but hospitals can cushion the impact using 340B funds
New Alzheimer’s Breakthroughs Demand A New Definition Of Dementia-Friendliness
Katherine O'Malley January 13, 2026
A more useful definition of dementia-friendliness must center on state policy.
When Drug Price Transparency Isn’t Enough
Kristina Smith December 9, 2025
Despite popular belief, drug price transparency does not guarantee affordable prices or fair access to medicines.
Want Better Health? Give Video Games A Try
Stuart Figueroa November 25, 2025
The public discourse about video games and health largely focuses on the potential risks, but what about the benefits? The answer may surprise you.
Trump’s Prescription Drug Policy: Rhetoric vs. True Reform
Katherine O'Malley October 29, 2025
Trump’s drug pricing policy promises headlines but not savings – Americans still pay triple, while real reform remains out of reach.
We Need Congress to Get Serious About Lowering Drug Costs
Katherine O'Malley October 9, 2025
Prescription drug costs in America are too high – will Congress rein in the middlemen in the supply chain that contribute to this problem?
Dual-Covered and Underserved: Can the “OpenTable of Health Care” Change That?
Kristina Smith October 2, 2025
Can digital health platforms like Zocdoc and Solv help close care gaps for dual-eligible patients?
Libraries are health hubs: why eliminate them?
Katherine O'Malley September 11, 2025
Cutting federal funding for the 9,000 public libraries serving as vital, local health hubs would negatively impact communities.
Measuring Biopharmaceutical Innovation in the Modern Era
Guest Post August 11, 2025
As the Inflation Reduction Act empowers Medicare to negotiate drug prices based in part on clinical benefit, and as the FDA more closely scrutinizes accelerated
Older Americans Backing Trump Now Face Cuts to Medicaid, Services
Katherine O'Malley July 1, 2025
The Trump is cutting the health care coverage, programs, and infrastructure older Americans rely on.
A Primer on Pharmacy Benefit Managers
Katherine O'Malley June 4, 2025
Pharmacy benefit managers (PBMs) have recently been the focus of media and legislation, but what do they actually do?
Making Life Easier for Patients with Alzheimer’s Disease and Their Caregivers
Katherine O'Malley April 30, 2025
Improving dementia care coordination will help patients and caregivers, reduce health care use, and lower costs.